Novel lipid-lowering therapies versus statins in primary prevention of cardiovascular disease
{{output}}
Background: Scarce evidence exists comparing clinical outcomes of novel lipid-lowering monotherapy with standard statin therapy for primary prevention. We compared clinical outcomes among primary prevention patients treated with ... ...
